Furthermore, MS patients have higher frequencies of CD4+ T cells specific for EBNA-1 relatively to healthy, seropositive individuals [18], while EBV-specific CD8+ T-cell responses in MS have been reported to be increased or decreased in different studies [19]–[23]. The gene discussed is CD4; the disease is myeloid sarcoma.